Amiodarone Lowers Heart Rate More Than Flecainide
Amiodarone is the clear choice for heart rate reduction, while flecainide has minimal to no effect on heart rate control. This is a fundamental pharmacologic difference between these two antiarrhythmic agents.
Key Pharmacologic Differences
Amiodarone's Rate-Lowering Effects
- Amiodarone promptly reduces ventricular rate and maintains this effect for at least 8 hours, even in patients who do not successfully cardiovert to sinus rhythm 1
- This rate control occurs through its multiple mechanisms of action, including beta-blocking properties and effects on AV nodal conduction
- The 2024 ESC guidelines recognize amiodarone's utility when cardioversion is desired in patients with structural heart disease, accepting there may be a delay in cardioversion 2
Flecainide's Lack of Rate Control
- Flecainide was no more effective than placebo in controlling ventricular rate in patients with atrial fibrillation 1
- Flecainide primarily slows intracardiac conduction (particularly His-Purkinje system) but does not usually alter heart rate 3
- The FDA label explicitly states that flecainide "does not usually alter heart rate, although bradycardia and tachycardia have been reported occasionally" 3
Clinical Context Matters
When Rate Control is the Priority
If your goal is heart rate reduction (not rhythm control):
- Choose amiodarone for its reliable rate-lowering effects
- Consider that amiodarone works even when cardioversion fails 1
Critical Safety Consideration with Flecainide
Flecainide can paradoxically INCREASE ventricular rate in atrial fibrillation/flutter by:
- Slowing atrial rate and facilitating 1:1 AV conduction in atrial flutter 3
- Creating a dangerous situation where ventricular response actually accelerates
The FDA label warns: "A paradoxical increase in the ventricular rate also may occur in patients with atrial fibrillation who receive flecainide acetate. Concomitant negative chronotropic therapy such as digoxin or beta-blockers may lower the risk of this complication" 3
Practical Algorithm
For heart rate control:
- Use amiodarone (not flecainide)
- If flecainide is used for rhythm control, always add AV nodal blocking agents (beta-blockers, calcium channel blockers, or digoxin) to prevent paradoxical rate acceleration
For rhythm control (cardioversion):
- Flecainide is superior for rapid cardioversion (73% success at 8 hours vs 28% for amiodarone) 1, 4
- But flecainide provides no rate control benefit
Bottom Line
These drugs serve different purposes: amiodarone for rate control, flecainide for rhythm control. If your question is specifically about which lowers heart rate more, amiodarone is unequivocally the answer.